Form 13-F position report

* MYRIAD GENETICS INC

Reported by VANGUARD GROUP INC

MYGN CUSIP 62855J104 Manager CIK 0000102909

Reported 9,152,347 shares, down 146,067 (1.6%) from the prior quarter.

Reported value -1.8%; share count -1.6% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2023
Shares 9,152,347 Quarter-end amount reported
Reported value $212,151,404 Fair value at quarter end
Consecutive quarters held 41 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-03-31 262621000
2021-06-30 273716000
2021-09-30 291681000
2021-12-31 252527000
2022-03-31 226211000
2022-06-30 163651000
2022-09-30 174170000
2022-12-31 135113652
2023-03-31 216002158
2023-06-30 212151404
2023-09-30 147002382
2023-12-31 190524020
2024-03-31 213961295
2024-06-30 246181852
2024-09-30 282436477
2024-12-31 145203200
2025-03-31 94622986
2025-06-30 49157288
2025-09-30 56990583
2025-12-31 50586032

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * MYRIAD GENETICS INC held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Added 8,225,371 +342,856 (4.3%) < 0.01% $50,586,032 2026-01-29
Q3 2025 Reduced 7,882,515 -1,374,978 (-14.9%) < 0.01% $56,990,583 2025-11-07
Q2 2025 Reduced 9,257,493 -1,410,262 (-13.2%) < 0.01% $49,157,288 2025-08-11
Q1 2025 Added 10,667,755 +76,712 (0.7%) < 0.01% $94,622,986 2025-05-09
Q4 2024 Added 10,591,043 +279,379 (2.7%) < 0.01% $145,203,200 2025-02-11
Q3 2024 Added 10,311,664 +246,993 (2.5%) < 0.01% $282,436,477 2024-11-13
Q2 2024 Added 10,064,671 +28,963 (0.3%) < 0.01% $246,181,852 2024-08-13
Q1 2024 Added 10,035,708 +81,475 (0.8%) < 0.01% $213,961,295 2024-05-10
Q4 2023 Added 9,954,233 +789,496 (8.6%) < 0.01% $190,524,020 2024-02-14
Q3 2023 Added 9,164,737 +12,390 (0.1%) < 0.01% $147,002,382 2023-11-14
Q2 2023 Reduced 9,152,347 -146,067 (-1.6%) < 0.01% $212,151,404 2023-08-14
Q1 2023 Reduced 9,298,414 -13,347 (-0.1%) < 0.01% $216,002,158 2023-05-15
Q4 2022 Added 9,311,761 +183,377 (2.0%) < 0.01% $135,113,652 2023-02-10
Q3 2022 Added 9,128,384 +121,704 (1.4%) < 0.01% $174,170,000 2022-11-14
Q2 2022 Added 9,006,680 +30,087 (0.3%) < 0.01% $163,651,000 2022-08-12
Q1 2022 Reduced 8,976,593 -172,928 (-1.9%) < 0.01% $226,211,000 2022-05-13
Q4 2021 Added 9,149,521 +116,324 (1.3%) < 0.01% $252,527,000 2022-02-14
Q3 2021 Added 9,033,197 +82,377 (0.9%) < 0.01% $291,681,000 2021-11-12
Q2 2021 Added 8,950,820 +326,155 (3.8%) < 0.01% $273,716,000 2021-08-13
Q1 2021 Added 8,624,665 +327,801 (4.0%) < 0.01% $262,621,000 2021-05-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

211 managers reported * MYRIAD GENETICS INC for Q2 2023.

Managers reporting * MYRIAD GENETICS INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 14,104,604 -23,104 < 0.01% $326,944,722 41 qtrs
VANGUARD GROUP INC This report Reduced 9,152,347 -146,067 < 0.01% $212,151,404 41 qtrs
Camber Capital Management LP Reduced 6,635,000 -365,000 5.01% $153,799,000 16 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 5,744,834 -986,005 0.03% $133,165,252 10 qtrs
STATE STREET CORPORATION Added 4,722,988 +120,069 < 0.01% $109,478,862 41 qtrs
GLENVIEW CAPITAL MANAGEMENT LLC Reduced 3,744,888 -450,224 1.96% $86,806,504 16 qtrs
EARNEST PARTNERS LLC Added 3,253,778 +192,940 0.42% $75,422,574 16 qtrs
Bank of America Corporation Reduced 2,970,821 -462,148 < 0.01% $68,863,631 41 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 2,673,471 -50,925 0.02% $61,970,696 41 qtrs
Artisan Partners Limited Partnership Added 2,538,065 +331,207 0.09% $58,832,347 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
54,916
None
9,097,431

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.